| Description | Brocresine is an aromatic L-amino acid decarboxylase inhibitor. It has both a peripheral and central action. |
| molecular weight | 218.05 |
| Molecular formula | C7H8BrNO2 |
| CAS | 555-65-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| References | 1. Lingappa JR, Zigmond RE. Limited recovery of pineal function after regeneration of preganglionic sympathetic axons: evidence for loss of ganglionic synaptic specificity. J Neurosci. 2013 Mar 13;33(11):4867-74. doi: 10.1523/JNEUROSCI.3829-12.2013. PubMed PMID: 23486957; PubMed Central PMCID: PMC3640627. 2. Youdim MB, Stephenson G, Ben Shachar D. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann N Y Acad Sci. 2004 Mar;1012:306-25. PubMed PMID: 15105275. 3. Arrue A, Ruiz-Ortega JA, Ugedo L, Giralt MT. Short-term effects of 3,4-methylenedioximethamphetamine on noradrenergic activity in locus coeruleus and hippocampus of the rat. Neurosci Lett. 2003 Feb 13;337(3):123-6. PubMed PMID: 12536039. 4. Arbogast LA, Voogt JL. Hypoprolactinemia decreases tyrosine hydroxylase activity in the tuberoinfundibular dopaminergic neurons acutely by protein dephosphorylation and chronically by changes in gene expression. Endocrine. 1995 Nov;3(11):801-6. doi: 10.1007/BF02935684. PubMed PMID: 21153124. |